Evidence
Crit Rev Oncol Hematol. 2024 May 28:104401. doi: 10.1016/j.critrevonc.2024.104401. Online ahead of print.
ABSTRACT
Several observations indicate that protein expression analysis by immunohistochemistry (IHC) remains relevant in individuals with non-small-cell lung cancer (NSCLC) when considering targeted therapy, as an early step in diagnosis and for therapy selection. Since the advent of next-generation sequencing (NGS), the role of IHC in testing for NSCLC biomarkers has been forgotten or ignored. We discuss how protein-level investigations maintain a critical role in defining sensitivity to lung cancer therapies in oncogene- and non-oncogene-addicted cases and in patients eligible for immunotherapy, suggesting that IHC testing should be reconsidered in clinical practice. We also argue how a panel of IHC tests should be considered complementary to NGS and other genomic assays. This is relevant to current clinical diagnostic practice but with potential future roles to optimize the selection of patients for innovative therapies. At the same time, strict validation of antibodies, assays, scoring systems, and intra- and interobserver reproducibility is needed.
PMID:38815876 | DOI:10.1016/j.critrevonc.2024.104401
Estimated reading time: 3 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
Cool Evidence: Engaging Young People and Students in Real-World Evidence
Real-Time Evidence Search [Psychiatry]
AI Research
Rediscovering immunohistochemistry in lung cancer
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
- Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience
- A case series of non-small cell lung cancer patients with EGFR or HER2 exon 20 insertion in Li Fraumeni syndrome
- A case series of non-small cell lung cancer patients with EGFR or HER2 exon 20 insertion in Li Fraumeni syndrome
- Prognostic and predictive biomarkers with therapeutic targets in nonsmall-cell lung cancer: A 2023 update on current development, evidence, and recommendation
- Prognostic and predictive biomarkers with therapeutic targets in nonsmall-cell lung cancer: A 2023 update on current development, evidence, and recommendation
- Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review)
- New Treatment Options for Patients With Oncogene-Addicted Non-Small Cell Lung Cancer Focusing on EGFR-Mutant Tumors
- Artificial Intelligence in Lung Cancer Imaging: From Data to Therapy
- EZH2 G553C significantly increases the risk of brain metastasis from lung cancer due to salt bridge instability
- EZH2 G553C significantly increases the risk of brain metastasis from lung cancer due to salt bridge instability
- Long-term survival of a patient with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) and untreated multiple brain metastases treated with zorifertinib: A case report
- Brain Metastasis from EGFR-Mutated Non-Small Cell Lung Cancer: Secretion of IL11 from Astrocytes Up-Regulates PDL1 and Promotes Immune Escape
- Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases
- Genetic profiles of oligometastatic non-small cell lung cancer and corresponding brain metastases
- HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis
- The Clinical Utility of a Tiered Approach to Pediatric Glioma Molecular Characterization for Resource-Limited Settings
- Recent advances in lung cancer research: unravelling the future of treatment
- A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada
- A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada
- Body Composition in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy
- Furmonertinib and intrathecal pemetrexed chemotherapy rechallenges osimertinib-refractory leptomeningeal metastasis in a non-small cell lung cancer patient harboring EGFR20 R776S, C797S, and EGFR21 L858R compound EGFR mutations: a case report
- Critical role of the gut microbiota in immune responses and cancer immunotherapy
- Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade
- Opportunities and challenges in accurate early diagnosis and treatment of lung cancer/pulmonary nodules
- Opportunities and challenges in accurate early diagnosis and treatment of lung cancer/pulmonary nodules
- Patient with mediastinal carcinoma of unknown primary with RET fusion achieves durable response with RET inhibition
- The involvement of ROS-regulated programmed cell death in hepatocellular carcinoma
- Microsatellite Instability, Mismatch Repair, and Tumor Mutation Burden in Lung Cancer
- Predictive Value of NLR and PLR in Driver-Gene-Negative Advanced Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: A Single Institutional Cohort Study
- ZNF692 promotes the migration and response to immunotherapy of clear cell renal cell carcinoma cells by targeting metabolic pathway
- Exploring Negated Entites for Named Entity Recognition in Italian Lung Cancer Clinical Reports
- Unveiling the altered metabolic pathways induced by nivolumab in non-small cell lung cancer via GC-MS metabolomics approach coupled with multivariate analysis
- The efficiency and safety of temozolomide and PD-1/L1 inhibitors in pretreated NSCLC with brain metastasis: a retrospective cohort
- TNF receptor 2 knockout mouse had reduced lung cancer growth and schizophrenia-like behavior through a decrease in TrkB-dependent BDNF level
- New funding for development of world's first lung cancer vaccine
- Machine Learning in Diagnosis and Prognosis of Lung Cancer by PET-CT
- Genetic correlation and causal associations between psychiatric disorders and lung cancer risk
- Integrated analysis of the role of PR/SET domain 14 in gastric cancer
- Integrated analysis of the role of PR/SET domain 14 in gastric cancer
- A pragmatic guide for management of adverse events associated with lorlatinib
- Dissecting the MUC5AC/ANXA2 signaling axis: implications for brain metastasis in lung adenocarcinoma
- Immune cell infiltration and inflammatory landscape in primary brain tumours
- Impact of PD-L1 Expression on the Overall Survival of Caucasian Patients with Advanced EGFR-Mutant NSCLC Treated with Frontline Osimertinib
- Does clinical T1N0 GGN really require checking for distant metastasis during initial staging for lung cancer?
- Multi-omics and artificial intelligence predict clinical outcomes of immunotherapy in non-small cell lung cancer patients
- Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial
- Artificial Intelligence-suggested Predictive Model of Survival in Patients Treated With Stereotactic Radiotherapy for Early Lung Cancer
- Is there a role for metastasis-directed therapy in bladder cancer?
- Systematic review and meta-analysis of deep learning applications in computed tomography lung cancer segmentation
- Improving Lung Cancer Screening Selection: The HUNT Lung Cancer Risk Model for Ever-Smokers Versus the NELSON and 2021 United States Preventive Services Task Force Criteria in the Cohort of Norway: A Population-Based Prospective Study
- Resistance to anti-EGFR through the successive and cumulative acquisition of two new oncogenic addictions: BRAF and ALK
- An Extensive Review on Lung Cancer Therapeutics Using Machine Learning Techniques: State-of-the-art and Perspectives
- Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer
- HER2-low breast cancer: insights on pathological testing
- Diagnostic performance of a deep-learning model using 18F-FDG PET/CT for evaluating recurrence after radiation therapy in patients with lung cancer
- Peristromal niches protect lung cancers from targeted therapies through a combined effect of multiple molecular mediators
- Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities
- Artificial Intelligence: Can It Save Lives, Hospitals and Lung Screening?
- Duodenal Papillary Metastasis of Lung Cancer with Bleeding Controlled by Endoscopic Treatment and Systemic Osimertinib Therapy: Case Report
- Stem cell-associated transcription factors in non-functioning pituitary neuroendocrine tumours
- Stem cell-associated transcription factors in non-functioning pituitary neuroendocrine tumours
- Deep learning-based assay for programmed death ligand 1 immunohistochemistry scoring in non-small cell lung carcinoma: Does it help pathologists score?
- Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockade
- ESCO2's oncogenic role in human tumors: a pan-cancer analysis and experimental validation
Evidence Blueprint
Rediscovering immunohistochemistry in lung cancer
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
Rediscovering immunohistochemistry in lung cancer
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
- Rare Driver Mutations in Advanced, Oncogene-Addicted Non-Small Cell Lung Cancer: A North Italian, Real-World, Registry Experience
- Lung cancer oncogene-directed therapy, fertility and pregnancy
- New options and open issues in the management of unresectable stage III and in early-stage NSCLC: a report from an expert panel of Italian medical and radiation oncologists - INTERACTION GROUP
- A case series of non-small cell lung cancer patients with EGFR or HER2 exon 20 insertion in Li Fraumeni syndrome
- A case series of non-small cell lung cancer patients with EGFR or HER2 exon 20 insertion in Li Fraumeni syndrome
- Prognostic and predictive biomarkers with therapeutic targets in nonsmall-cell lung cancer: A 2023 update on current development, evidence, and recommendation
- Prognostic and predictive biomarkers with therapeutic targets in nonsmall-cell lung cancer: A 2023 update on current development, evidence, and recommendation
- Targeting the Hippo pathway to prevent radioresistance brain metastases from the lung (Review)
- New Treatment Options for Patients With Oncogene-Addicted Non-Small Cell Lung Cancer Focusing on EGFR-Mutant Tumors
- Artificial Intelligence in Lung Cancer Imaging: From Data to Therapy
- Efficacy and safety of nintedanib and docetaxel in patients with previously treated lung non-squamous non-small cell lung cancer: a multicenter retrospective real-world analysis
- EZH2 G553C significantly increases the risk of brain metastasis from lung cancer due to salt bridge instability
- EZH2 G553C significantly increases the risk of brain metastasis from lung cancer due to salt bridge instability
- Immune Checkpoint Inhibitors in "Special" NSCLC Populations: A Viable Approach?
- Brain metastasis screening in the molecular age
- Long-term survival of a patient with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC) and untreated multiple brain metastases treated with zorifertinib: A case report
- Brain Metastasis from EGFR-Mutated Non-Small Cell Lung Cancer: Secretion of IL11 from Astrocytes Up-Regulates PDL1 and Promotes Immune Escape
- Wilms' tumour gene 1 (WT1) enhances non-small cell lung cancer malignancy and is inhibited by microRNA-498-5p
- Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases
- Genetic profiles of oligometastatic non-small cell lung cancer and corresponding brain metastases
- HERC5 downregulation in non-small cell lung cancer is associated with altered energy metabolism and metastasis
- The Clinical Utility of a Tiered Approach to Pediatric Glioma Molecular Characterization for Resource-Limited Settings
- Apoptosis-targeted gene therapy for non-small cell lung cancer using chitosan-poly-lactic-co-glycolic acid -based nano-delivery system and CASP8 and miRs 29A-B1 and 34A
- Recent advances in lung cancer research: unravelling the future of treatment
- Whole stromal fibroblast signature is linked to specific chemokine and immune infiltration patterns and to improved survival in NSCLC
- A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada
- A population-based analysis of the management of symptoms of depression among patients with stage IV non-small cell lung cancer (NSCLC) in Ontario, Canada
- Body Composition in Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy
- Furmonertinib and intrathecal pemetrexed chemotherapy rechallenges osimertinib-refractory leptomeningeal metastasis in a non-small cell lung cancer patient harboring EGFR20 R776S, C797S, and EGFR21 L858R compound EGFR mutations: a case report
- Critical role of the gut microbiota in immune responses and cancer immunotherapy
- Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade
- Opportunities and challenges in accurate early diagnosis and treatment of lung cancer/pulmonary nodules
- Opportunities and challenges in accurate early diagnosis and treatment of lung cancer/pulmonary nodules
- Patient with mediastinal carcinoma of unknown primary with RET fusion achieves durable response with RET inhibition
- The involvement of ROS-regulated programmed cell death in hepatocellular carcinoma
- Gene therapy in cancer
- Racial/Ethnic disparities in exposure to neighborhood violence and lung cancer risk in Chicago
- Microsatellite Instability, Mismatch Repair, and Tumor Mutation Burden in Lung Cancer
- Predictive Value of NLR and PLR in Driver-Gene-Negative Advanced Non-Small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitors: A Single Institutional Cohort Study
- ZNF692 promotes the migration and response to immunotherapy of clear cell renal cell carcinoma cells by targeting metabolic pathway
- Exploring Negated Entites for Named Entity Recognition in Italian Lung Cancer Clinical Reports
- Glioma arising in the setting of mismatch repair deficiency-rare or are we missing it?
- Unveiling the altered metabolic pathways induced by nivolumab in non-small cell lung cancer via GC-MS metabolomics approach coupled with multivariate analysis
- The efficiency and safety of temozolomide and PD-1/L1 inhibitors in pretreated NSCLC with brain metastasis: a retrospective cohort
- TNF receptor 2 knockout mouse had reduced lung cancer growth and schizophrenia-like behavior through a decrease in TrkB-dependent BDNF level
- Music therapy, quality of life and efficacy of immunotherapy for NSCLC
- New funding for development of world's first lung cancer vaccine
- Machine Learning in Diagnosis and Prognosis of Lung Cancer by PET-CT
- Intratumoral abundance of M2-macrophages is associated with unfavorable prognosis and markers of T-cell exhaustion in small cell lung cancer patients
- Genetic correlation and causal associations between psychiatric disorders and lung cancer risk
- Integrated analysis of the role of PR/SET domain 14 in gastric cancer
- Integrated analysis of the role of PR/SET domain 14 in gastric cancer
- A pragmatic guide for management of adverse events associated with lorlatinib
- Pan-Cancer Profiling and Digital Pathology Analysis Reveal Negative Prognostic Biomarker ZPR1 Associated with Immune Infiltration and Treatment Response in Hepatocellular Carcinoma
- Dissecting the MUC5AC/ANXA2 signaling axis: implications for brain metastasis in lung adenocarcinoma
- α5-nAChR/STAT3/CD47 axis contributed to nicotine-related lung adenocarcinoma progression and immune escape
- Nicotinic acetylcholine receptors in cancer: Limitations and prospects
- Immune cell infiltration and inflammatory landscape in primary brain tumours
- Impact of PD-L1 Expression on the Overall Survival of Caucasian Patients with Advanced EGFR-Mutant NSCLC Treated with Frontline Osimertinib
- Does clinical T1N0 GGN really require checking for distant metastasis during initial staging for lung cancer?
- SOMATIC DEFICIENT MISMATCH REPAIR ASSESSED BY IMMUNOHISTOCHEMISTRY AND CLINICAL FEATURES IN BRAZILIAN GLIOBLASTOMA PATIENTS
- Multi-omics and artificial intelligence predict clinical outcomes of immunotherapy in non-small cell lung cancer patients
- The oncogenic protein kinase/ATPase RIOK1 is up-regulated via the MYC/E2F transcription factor axis in prostate cancer
- Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer: a randomized phase 2 trial